Literature DB >> 2920050

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus.

C P Maury1, A M Teppo.   

Abstract

In view of recent data demonstrating defective production of tumor necrosis factor alpha (TNF cachectin) in murine autoimmune lupus nephritis, we studied the serum levels of TNF in 22 patients with systemic lupus erythematosus (SLE), using a specific radioimmunoassay. Patients with SLE had either normal or slightly elevated levels of TNF when compared with healthy control subjects. All 5 SLE patients with concomitant infections had elevated levels of TNF; those with systemic bacterial infection had markedly raised levels (median 260 pg/ml; normal less than 40). These results show that SLE in humans is not associated with a depressed level of circulating TNF, and that in SLE patients with infection, the level of TNF in the circulation increases in a manner similar to that in other subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920050     DOI: 10.1002/anr.1780320206

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

1.  The proinflammatory cytokine tumor necrosis factor-α excites subfornical organ neurons.

Authors:  Nick J Simpson; Alastair V Ferguson
Journal:  J Neurophysiol       Date:  2017-06-21       Impact factor: 2.714

Review 2.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.

Authors:  E Svenungsson; M Andersson; L Brundin; R van Vollenhoven; M Khademi; A Tarkowski; D Greitz; M Dahlström; I Lundberg; L Klareskog; T Olsson
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 4.  [Biologics therapy for systemic lupus erythematosus. Current situation].

Authors:  B F Hoyer; T Dörner
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

Review 5.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

Review 7.  New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies.

Authors:  G A MacGowan; D M McNamara
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

8.  Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha.

Authors:  M Mahatma; N Agrawal; E Z Dajani; S Nelson; C Nakamura; J Sitton
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

9.  Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus.

Authors:  M Pallis; D K Robson; D O Haskard; R J Powell
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

10.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.